We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Objective: This study evaluated the efficacy and tolerability of FPF 1070 (cerebrolysin) in patients with mild to moderately severe Alzheimer's disease (AD). Methods: The trial was of a ...

WHEATON, Ill., March 20, 2025--First Trust Intermediate Duration Preferred & Income Fund (the "Fund") (NYSE: FPF) has declared the Fund’s regularly scheduled monthly common share distribution in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...